Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trivivac Immunogenicity and Reactogenicity in Infants
NCT01763268Phase 3Unknown
- Sponsor
- Queen Sirikit National Institute of Child Health
- Start
- Sep 2012
- Primary completion
- Jan 2015
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Trivivac in measles, mumps, rubella, sponsored by Queen Sirikit National Institute of Child Health. Status: unknown.
02
Drugs
Trivivac
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT01763268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763268.